Weller, M A rationale for NMDA receptor antagonist therapy of the neuroleptic malignant syndrome. [electronic resource] - Medical hypotheses Aug 1992 - 329-33 p. digital Publication Type: Journal Article ISSN: 0306-9877 Standard No.: 10.1016/0306-9877(92)90027-a doi Subjects--Topical Terms: Amantadine--therapeutic useHumansModels, BiologicalMuscle Spasticity--drug therapyNeuroleptic Malignant Syndrome--drug therapyReceptors, N-Methyl-D-Aspartate--antagonists & inhibitorsSynaptic Transmission--drug effects